☆ 4.3 Article

Distinct phenotypes in a cohort of anti-CASPR2 associated neurological syndromes

CLINICAL NEUROLOGY AND NEUROSURGERY (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?

Alexander Marx et al.

Summary: This article provides an overview of the new developments in the fifth edition of the WHO classification of thymic epithelial tumors, mediastinal germ cell tumors, and mesenchymal neoplasms, focusing on diagnostic, molecular, and conceptual advances. Diagnostic advances include immunohistochemical characterization and the identification of genetic translocations. Molecular and tumor biological advancements include the finding that thymomas and most thymic carcinomas lack currently targetable mutations, but typically have a PD-L1(high) phenotype. Additionally, conceptual advancements for the classification of thymic NETs are discussed.

JOURNAL OF THORACIC ONCOLOGY (2022)

Add to Collection

Article Ophthalmology

Isolated Adie Pupil Associated With Anti-CASPR2 Antibodies

João Moura et al.

JOURNAL OF NEURO-OPHTHALMOLOGY (2022)

Add to Collection

Letter Clinical Neurology

Contactin-Associated Protein-Like 2 (CASPR2)-Associated Movement Disorder in a Child

Ram Bhupal Reddy Nagireddy et al.

MOVEMENT DISORDERS CLINICAL PRACTICE (2021)

Add to Collection

Article Immunology

Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study

Xiaoxiao Qin et al.

Summary: Autoimmune encephalitis associated with CASPR2 antibody demonstrates diverse clinical characteristics, with a lower relapse rate and good response to immunotherapy, indicating a favorable short-term prognosis. Further evaluation for long-term prognosis is needed.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Clinical Neurology

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes

Francesc Graus et al.

Summary: The updated diagnostic criteria for PNS proposed by a panel of experts involve the classification of high-risk, intermediate-risk, and low-risk phenotypes, as well as the introduction of a new classification of evidence for PNS.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Add to Collection

Article Clinical Neurology

P-AD003. Autonomic dysfunction in CASPR2 antibody associated neurological disease

Sumanth Shivaram et al.

CLINICAL NEUROPHYSIOLOGY (2021)

Add to Collection

Article Clinical Neurology

Autoimmune Encephalitis Resembling Dementia Syndromes

Anna E. M. Bastiaansen et al.

Summary: This study evaluates how frequently autoimmune encephalitis (AIE) mimics dementia in middle-aged and older patients, and provides red flags for AIE, including rapidly progressive cognitive decline, subtle seizures, and abnormalities in ancillary testing atypical for neurodegeneration.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Add to Collection

Article Clinical Neurology

CASPR2-Related Morvan Syndrome Autonomic, Polysomnographic, and Neuropsychological Observations

Panda Sudha Swayang et al.

Summary: Morvan syndrome characterized by hyperexcitability of central, autonomic, and peripheral systems due to CASPR2 antibody. Clinical features involve multiple systems, EMG and autonomic function tests aid in diagnosis, treatment mainly with steroids.

NEUROLOGY-CLINICAL PRACTICE (2021)

Add to Collection

Review Clinical Neurology

Systematic review of the clinical spectrum of CASPR2 antibody syndrome

Matthew Boyko et al.

JOURNAL OF NEUROLOGY (2020)

Add to Collection

Article Anesthesiology

Heterogeneous presentation of caspr2 antibody-associated peripheral neuropathy - A case series

Erik Ellwardt et al.

EUROPEAN JOURNAL OF PAIN (2020)

Add to Collection

Article Clinical Neurology

Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features

Sergio Muniz-Castrillo et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Add to Collection

Letter Clinical Neurology

Expanding clinical spectrum of Caspr2 antibody-associated disease: warning on brainstem involvement and respiratory failure

Roberta Di Giacomo et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)

Add to Collection

Review Clinical Neurology

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes

Sophie N. M. Binks et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Add to Collection

Review Neurosciences

Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases

Margaux Saint-Martin et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2018)

Add to Collection

Review Medicine, General & Internal

Antibody-Mediated Encephalitis

Josep Dalmau et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Editorial Material Medicine, General & Internal

Morvan syndrome as a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies

Thiago Cardoso Vale et al.

LANCET (2017)

Add to Collection

Article Clinical Neurology

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis

Bastien Joubert et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)

Add to Collection

Article Clinical Neurology

Persistent microglial activation and synaptic loss with behavioral abnormalities in mouse offspring exposed to CASPR2-antibodies in utero

Ester Coutinho et al.

ACTA NEUROPATHOLOGICA (2017)

Add to Collection

Article Clinical Neurology

The clinical spectrum of Caspr2 antibody-associated disease

Agnes van Sonderen et al.

NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

Sarosh R. Irani et al.

BRAIN (2010)

Add to Collection

Article Clinical Neurology

Phenotypic variants of autoimmune peripheral nerve hyperexcitability

Ian K. Hart et al.

BRAIN (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.